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Abstract 
 
To study T cell apoptosis during spontaneous recovery from experimental autoimmune 
encephalomyelitis (EAE), we extracted lymphocytes from the spinal cords of Lewis rats with EAE induced 
by inoculation with myelin basic protein (MBP) and adjuvants. Using flow cytometry we assessed the 
numbers of CD5+ and TCRαβ+ lymphocytes, as well as Vβ8.2+ lymphocytes, which constitute the 
predominant encephalitogenic MBP-reactive cells in Lewis rats. Rats developed neurological signs of 
disease 10-12 days after inoculation. The peak of disease was on day 14 after inoculation and was followed 
by clinical recovery. The numbers of CD5+, TCRαβ+ and Vβ8.2+ cells obtained from the spinal cord were 
greatest on day 13. During spontaneous clinical recovery, there was a decline in the numbers of all the 
cells studied, with a selective loss of Vβ8.2+ cells from the CD5+ and TCRαβ+ populations. To determine 
whether the decline in lymphocyte numbers was due to apoptosis, we used simultaneous surface labelling and 
propidium iodide staining of the DNA of the cells extracted from the spinal cord. From day 14 onwards, there 
was selective enrichment of Vβ8.2+ cells in the apoptotic population, and the percentage of Vβ8.2+ cells 
undergoing apoptosis was greater than the percentages of CD5+ and TCRαβ+ cells undergoing apoptosis. 
These findings indicate that recovery from acute EAE is associated with the selective apoptosis, in the 
central nervous system, of these disease-relevant cells. The findings in this study of actively induced EAE are 
similar to those of our previous study of EAE induced by transfer of encephalitogenic MBP-specific T cells 
(Z. Tabi et al., Eur. J. Immunol. 24: 2609-2617, 1994) and further support the hypothesis that selective 
apoptosis of autoreactive T cells in the central nervous system is of primary importance in spontaneous 
recovery from EAE. 
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1. Introduction 
 
Experimental autoimmune encephalomyelitis 
(EAE) can be induced in susceptible animals by 
inoculation with myelin antigens and adjuvants or 
by the passive transfer of T lymphocytes activated 
by these antigens. EAE is the best available animal 
model of multiple sclerosis, but the acute form of 
EAE differs from multiple sclerosis in that animals 
recover spontaneously and are resistant to further 
episodes of disease. Recovery from acute EAE is 
associated with loss of T lymphocytes from the 
central nervous system (CNS) (Matsumoto and 
Fujiwara, 1987; McCombe et al., 1992; Zeine and 
Owens, 1993). We have previously reported the 
presence of apoptotic T cells in the CNS in EAE 
(Pender et al., 1992) and suggested that the 
apoptotic elimination of T cells may contribute to 
the resolution of inflammation in the CNS (Pender 
et al., 1991, 1992). In the Lewis rat, 
encephalitogenic T lymphocytes reactive with 
MBP predominantly use the Vβ8.2 chain of the T 
cell receptor (TCR) (Chluba et al., 1989; Bums et 
al., 1989), and Vβ8.2+ cells constitute the 
predominant T cell population in the CNS during 
the early stages of MBP-EAE (Tsuchida et al., 
1993). In Lewis rats, Vβ8.2+ cells are necessary 
for the development of MBP-EAE (Imrich et al., 
1995). We have previously shown that the disease-
relevant Vβ8.2+ cells are selectively eliminated by 
apoptosis in the CNS during spontaneous recovery 
from EAE induced by the passive transfer of a 
Vβ8.2+ T cell clone specific for the 72-89 peptide 
of MBP (Tabi et al., 1994). This selective apoptosis 
was associated with a specific down-regulation of the 
MBP72-89-specific T cell response in the CNS (Tabi et 
al., 1995). Furthermore, in contrast to autoreactive T 
cells, the non-autoreactive T cells that accumulate in 
the CNS during the course of EAE recirculate to the 
peripheral lymphoid organs (Tabi et al., 1995). 
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The present study was performed to quantify the 
numbers of lymphocytes in the spinal cord, to assess 
lymphocyte apoptosis in the spinal cord and to 
determine whether there is selective apoptosis of 
disease-relevant Vβ8.2+ cells in the CNS in EAE 
actively induced by inoculation with MBP. Actively 
induced EAE differs from EAE induced by passive 
transfer in several important respects. In the actively 
induced form, T lymphocytes reactive with multiple 
MBP epitopes may be stimulated, whereas in EAE 
induced by cloned encephalitogenic cells, all the 
effector cells are directed against a single epitope. 
Further-more, in actively induced EAE, T cells are 
activated in the lymph nodes draining the site of 
inoculation and may be available to enter the CNS 
over a prolonged period of time, whereas passive 
EAE is induced by a single injection of cells which 
rapidly enter the CNS. Finally, in EAE induced by 
inoculation with antigen and adjuvants, T cells 
reactive with mycobacterial antigens may be 
activated at the same time as encephalitogenic cells 
and may also enter the CNS. We now show that, 
despite these complicating factors, there is evidence 
of selective apoptosis of Vβ8.2+ cells in the CNS 
during recovery from this form of EAE. 
2. Methods 
2.1. Animals 
Lewis rats (JC strain), 13 females and 90 males 
aged 8-10 weeks, were obtained from the animal 
breeding facility of the University of Queensland. 
 
2.2. Preparation of inoculum and induction of EAE 
Myelin basic protein (MBP) was prepared from 
guinea pig brains by the method of Deibler et al. 
(1972). MBP in 0.9% saline was emulsified in an 
equal volume of incomplete Freund's adjuvant 
containing 4 mg/ml Mycobacterium butyricum. 
Under anaesthesia, rats were inoculated in one 
hindfootpad with 0.1 ml emulsion. The total dose of 
MBP was 50 µg per rat. 
 
2.3. Clinical assessment 
Tail, hindlimb and forelimb weakness were each 
graded on a scale of 0 (no weakness) to 4 (total 
paralysis) as previously described (Pender, 1986). 
The total clinical score was obtained by adding these 
three scores (maximum = 12). 
 
 
 
2.4. Extraction of cells from the spinal cord 
Using our previously described methods (Tabi et 
al., 1994), cells were isolated from the spinal cord of 
rats perfused with ice-cold saline. The entire spinal 
cord was removed by insufflation, weighed, and a 
single cell sus-pension in ice-cold RPMI containing 
1% foetal calf serum was prepared by passage of the 
spinal cord through a 200-mesh stainless steel sieve. 
The cell suspension was mixed with isotonic Percoll 
(Percoll:HBSS 9:1) in a 3:2 ratio (density 1.052) in 
50 ml centrifuge tubes and spun for 25 min at 640 g 
at 4°C. The cell pellet and the last 9ml supernatant 
were resuspended, transferred to a conical centrifuge 
tube, underlaid with 1 ml Ficoll and spun for 20 min 
at 600 g at 4°C. The cells from the interface above 
the Ficoll were collected, washed and counted. To 
enrich for T lymphocytes, the cells were then passed 
through a nylon wool column, as previously 
described (Tabi et al., 1994). 
 
2.5. Monoclonal antibodies 
Mouse monoclonal antibodies specific for CD5 
(OX19), the αβ TCR (R73) and CD45 (OX1) were 
obtained from Dr J Sedgwick. Antibody to Vβ8.2 
was kindly provided by Dr T Hünig. Mouse IgGl κ 
(Dako) was used as an isotype control antibody. The 
secondary antibody was fluorescein isothiocyanate 
(FITC)-conjugated F(ab')2 rabbit anti-mouse IgG 
(STAR 41) (Serotec). The primary and secondary 
antibodies were diluted in PBS/azide (1% foetal calf 
serum/1% sodium azide in phosphate buffered saline 
(PBS)). 
 
2.6. Labelling of cells and flow cytometric analysis 
Using our previously described methods for 
simultaneous detection of surface antigens and DNA 
fragmentation characteristic of apoptosis (Tabi et al., 
1994), cells were labelled with monoclonal 
antibodies, permeabilized and labelled with 
propidium iodide (PI). Briefly, aliquots of 105-106 
cells were washed with a 1:1 solution of serum in 
PBS/azide, then incubated with primary antibodies 
for 30 min at 4°C. Samples were washed, incubated 
with the secondary antibody for 30 min at 4°C in the 
dark, and washed twice with PBS to remove 
proteins in solution. Samples were resuspended in 1 
ml of ice-cold 50% ethanol and fixed overnight at 
4°C. The following day, the ethanol was removed by 
washing the cells in PBS, and the cell pellets were 
resuspended in an appropriate volume (100-300 µl) 
of PI-staining solution (freshly prepared by diluting 
stock solution [5mg/ml RNase/250 µg/ml PI in 0.1M 
PBS, pH 7.4/ 0.1 mM EDTA] 1:4 with PBS/azide). 
Samples were kept on ice in the dark  
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and analyzed using a Becton Dickinson FACScan 
within 1 h. Analysis of flow cytometric data was 
performed as follows. For surface labelling, the 
isotype control sample values were subtracted from 
all other sample values to remove back ground. The 
percentage of antibody-positive cells was 
determined from histograms of FITC fluorescence 
intensity. To analyze levels of apoptosis, histograms 
of PI fluorescence were obtained, as described by 
Telford et al. (1991). Apoptotic events were defined 
as those having lower fluorescence than the sharply 
defined Go/G1 peak. To avoid detecting nuclear 
debris, events with a low level of red (PI) 
fluorescence were not collected. Electronic 
compensation for two-colour analysis ensured 
unchanged FITC distribution following PI labelling 
of DNA. 
3. Results 
 
3.1. Course of disease 
 
Rats developed neurological signs of EAE on 
days 10-12 after inoculation. The peak of disease 
was on day 14, after which the rats gradually 
recovered. The mean clinical scores at the time of 
study are shown in Table 1. On each day after 
inoculation we analyzed the cells from 2-4 groups of 
rats, with each group containing the pooled cells 
extracted from 4-7 rats. 
 
3.2. Cell numbers throughout the course of disease 
 
Fig. 1 shows the numbers of CD5+, TCRαβ+ and 
Vβ8.2+ cells extracted from the spinal cord 
throughout the course of EAE. The numbers of cells 
with these surface markers were greatest on day 13, 
the day before the peak of clinical disease, and 
declined thereafter. 
To determine whether clinical recovery from 
actively-induced acute MBP-EAE is associated with 
a selective loss of Vβ8.2+ cells from the CD5+ and 
TCRαβ+ populations in the spinal cord, we studied 
the proportion of CD5+ and TCRαβ+ cells that were 
Vβ8.2+ on different days after inoculation, making 
the assumption that the Vβ8.2+ cells were CD5+ and 
TCRαβ+ (Fig. 2). The percentages of CD5+ and 
TCRαβ+ cells that were Vβ8.2+ reached a peak on 
day 14 and then declined during clinical recovery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Day after inoculation 
Fig. 1. Numbers (cells x 105/g) of CD5+, TCRαβ+ and Vβ8.2+ 
cells extracted from the spinal cords of rats with actively 
induced MBP-EAE on days 12-18 after inoculation. The 
numbers of cells were maximal on day 13, the day before the 
peak of clinical illness. Thereafter the numbers declined as 
the animals recovered clinically. 
3.3. Numbers of apoptotic cells throughout the 
course of disease 
 
We used flow cytometry to assess apoptosis of 
CD5+ cells, TCRαβ+ cells and Vβ8.2+ cells in the 
spinal cord. Fig. 3 shows that apoptotic cells with 
these surface markers were present in the cells 
extracted from the spinal cord. From day 14 
onwards the proportion of Vβ8.2+ cells that were 
apoptotic was greater than the proportions of the 
total. 
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Day after inoculation 
Fig. 2. Percentages of CD5+ TCRαβ+  cells extracted from the spinal 
cord that were Vβ8.2+ on days 12-18 after inoculation. The 
percentages were greatest on day 14, the day of the peak of clinical 
disease. The percentages of cells that were Vβ8.2+  then declined to a 
level about half that of the maximum percentages. 
 
 
 
Day after inoculation 
Fig. 3. Percentages of CD5+, TCRαβ+ and Vβ8.2+ spinal cord 
cells that are apoptotic in rats at days 12-18 after inoculation 
with MBP and adjuvants. From days 14-18, the percentage of 
Vβ8.2+ cells that were apoptotic was greater than the 
percentages of total CD5+ and TCRαβ+ cells that were 
apoptotic, indicating selective apoptosis of Vβ8.2+ cells. 
 
 
 
 
 
CD5+- and TCRαβ+ cell populations that were apoptotic, 
indicating that there is selective apoptosis of Vβ8.2+ cells. 
Table 2 shows the ratios (percent), in the apoptotic and 
non-apoptotic cell populations, of Vβ8.2+ to CD5+ cells 
and Vβ8.2+ to TCRαβ+ cells. The degree of enrichment of 
Vβ8.2+ cells within the apoptotic CD5+ and TCRαβ+ 
populations was calculated by dividing the proportion of 
apoptotic cells that were Vβ8.2+ by the proportion of non-
apoptotic cells that were Vβ8.2+ for each population. On 
days 14-18 after inoculation, the proportion of Vβ8.2+ cells 
in the apoptotic CD5+ population was 2.6-5.0 times the 
proportion of Vβ8.2+ cells in the non-apoptotic CD5+ 
population. Similarly, the proportion of Vβ8.2+ cells in the 
apoptotic TCRαβ+ population was 1.8-2.7 times the 
proportion of Vβ8.2+ cells in the non-apoptotic TCRαβ+ 
population. These results indicate that Vβ8.2+ T lympho-
cytes. selectively undergo apoptosis in the CNS during 
recovery from actively induced MBP-EAE. 
4. Discussion 
In the present study we have shown that spontaneous 
recovery from acute EAE actively induced by inoculation 
with MBP is associated with selective apoptosis of Vβ8.2+ T 
cells in the spinal cord. There is evidence that T cells that 
mediate MBP-EAE are Vβ8.2+ (Chluba et al., 1989; Burns 
et al., 1989), that Vβ8.2+ cells constitute the pre-dominant 
T cell population in the CNS during the early stages of 
MBP-EAE (Tsuchida et al., 1993) and, in Lewis rats, that 
Vβ8.2+ cells are necessary for the development of MBP-
EAE (Imrich et al., 1995). We have previously presented 
evidence that Vβ8.2+ T cells reactive to MBP72-89 are 
selectively eliminated from the CNS by apoptosis during 
recovery from EAE induced by the passive transfer of an 
encephalitogenic Vβ8.2+ MBP72-89-reactive T cell clone 
(Tabi et al., 1994, 1995). We suggest that the enhanced 
apoptosis of the Vβ8.2+ T cells in the 
.
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CNS during recovery from EAE is likely to be related to the 
autoreactive nature of these encephalitogenic cells, with 
activated CNS-reactive cells undergoing preferential 
apoptosis in the CNS. 
In the present model, the proportions of CNS-infiltrating 
CD5+ cells and TCRαβ+ cells that were Vβ8.2+ were highest 
on day 14 and then declined to levels half those of the 
maximum levels. This is evidence that during recovery from 
EAE there is a selective loss of Vβ8.2+ T cells from the 
spinal cord lymphocyte population. These figures are in 
agreement with the results of a study by Tsuchida et al. 
(1993) in the same model, which found that the proportion 
of TCRαβ+ cells that were Vβ8.2+ declined from 16.6% on 
day 12 to 8.2% on day 16. The selective loss of Vβ8.2+ cells 
from the CNS in actively induced MBP-EAE is less than 
that which occurs in passively transferred MBP-EAE (Tabi 
et al., 1994). The lesser loss in actively induced MBP-EAE 
may have two explanations. Firstly, new Vβ8.2+ 
encephalitogenic cells produced in the periphery may enter 
the CNS in actively induced EAE, thus masking the loss of 
Vβ8.2+ cells from the CNS. Secondly, in actively induced 
EAE, some non-Vβ8.2+ T cells may also be autoreactive and 
may be lost from the CNS by the same mechanism that 
leads to the loss of the autoreactive Vβ8.2+ encephalitogenic 
cells. 
To detect apoptosis in cells extracted from the spinal 
cord, we used flow cytometry to analyse DNA labelling 
with PI. This technique is widely used for the measurement 
of apoptosis and we have previously shown that cells that 
have reduced PI staining also have DNA fragmentation 
characteristic of apoptosis (Tabi et al., 1994). We found 
apoptosis of cells in the CD5+, TCRαβ+, and Vβ8.2+ 
populations. During clinical recovery the percent-age of 
Vβ8.2+ cells that were apoptotic was greater than the 
percentages of the CD5+ and TCRαβ+ populations that were 
apoptotic, indicating that there was selective (or 
preferential) apoptosis of Vβ8.2+ cells in the spinal cord. 
Selectivity of apoptosis of Vβ8.2+ cells was also detected by 
calculating the proportions of Vβ8.2+ cells in the apoptotic 
and non-apoptotic T cell populations. The proportion of 
Vβ8.2+ cells in the apoptotic CD5+ population was 2.6-5.0 
times the proportion of Vβ8.2+ cells in the non-apoptotic 
CD5+ population during recovery from EAE. Using the 
same calculations we have previously demonstrated a 
sevenfold enrichment of Vβ8.2+ cells in the apoptotic CD5+ 
population in the CNS, 6 days after the passive transfer of a 
Vβ8.2+ MBP-specific encephalitogenic T cell clone (Tabi et 
al., 1994). 
Our results therefore indicate that there is selective loss 
of Vβ8.2+ T cells from the CNS during spontaneous 
recovery from actively induced MBP-EAE and that this is 
due to the selective elimination of these cells by apoptosis. 
In the present study we did not determine the frequencies of 
MBP-reactive T cells in the CNS during the course of EAE. 
However, we have previously presented evidence that 
encephalitogenic Vβ8.2+ MBP72-89-reactive T cells are 
selectively eliminated from the CNS by apoptosis during 
spontaneous recovery from passively transferred EAE,  
 
 
whereas the non-CNS-reactive T cells that accumulate in the 
CNS subsequently recirculate to the peripheral lymphoid 
organs (Tabi et al., 1994, 1995). Our present finding of the 
selective apoptotic elimination of Vβ8.2+ cells in the CNS in 
actively induced EAE is consistent with our previous 
observation that the frequency of MBP72-89-reactive T cells 
in the spleen is much lower than the frequency of 
ovalbumin-reactive T cells 38 days after inoculation with 
MBP, ovalbumin and adjuvants (Tabi et al., 1995). 
Thus, we interpret our findings of selective loss and 
selective apoptosis of Vβ8.2+ cells in the CNS in actively 
induced MBP-EAE as being related to the autoreactive nature 
of these cells. This appears to be the best explanation for a 
difference in the behaviour, in the CNS, of these cells 
compared to the total T cell population. A mechanism that 
results in the preferential apoptosis of autoreactive 
encephalitogenic T cells in the CNS in EAE would also be 
expected to apply to any autoreactive non-Vβ8.2+ T cells that 
might also be present. We have previously suggested that 
apoptosis of autoreactive T cells in the CNS may represent 
activation-induced cell death, following interaction with non-
professional antigen-presenting cells, such as astrocytes or 
microglia (Pender et al., 1992). This form of cell death is 
antigen-specific and is dependent on engagement of the TCR. 
The finding of Schmied et al. (1993) that T cell apoptosis is 
mainly localized to the CNS in EAE would be consistent 
with a local factor being important in producing apoptosis. 
The background level of apoptosis of other T cells in the 
CNS may be due to antigen-nonspecific factors such as 
endogenous corticosteroids which are important in recovery 
from EAE (Levine et al., 1980; MacPhee et al., 1989) and 
which can induce apoptosis in mature T cells in vitro (Nieto 
and Lopez-Rivas, 1989; Zubiaga et al., 1992; Tuosto et al., 
1994). 
These findings may be relevant to the understanding of 
multiple sclerosis. If apoptosis of encephalitogenic T cells in 
the CNS is important in recovery from CNS autoimmune 
disease, then agents that enhance apoptosis of CNS-reactive 
cells might enhance recovery from multiple sclerosis. 
Conversely, a failure of T cell apoptosis in the CNS might 
contribute to the ongoing nature of disease in multiple 
sclerosis. 
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